Accessibility of Biologic Drugs in Morocco: Comparison with FDA and EMA Approvals (2015–2025)
This study aims to evaluate the rates and timeframes of the availability and reimbursement of biologic drugs in Morocco, after approval by the Food and Drug Administration (FDA) or the European Medicines Agency (EMA). The results will help to identify disparities in access and promote rapid access t...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2026-04-01
|
| Col·lecció: | Journal of Market Access & Health Policy |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2001-6689/14/2/21 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|